title: Pyloric stenosis associated Crohn's disease responding to adalimumab therapy.
abstract: Gastroduodenal Crohn's disease (CD) is rare and the response to standard medical therapy is often poor. Anti-tumor necrosis factor therapy has revolutionised the treatment of CD. We present a patient with pyloric stenosis associated with CD which improved with Adalimumab therapy. We recommend considering anti-tumor necrosis factor therapy in symptomatic gastroduodenal CD.
authors.affiliation: Sameer Gaggar, Nicholas Thompson, Department of Gastroenterology, Freeman Hospital, NE7 7DN Newcastle, United Kingdom.
authors.forename: Sameer
authors.initials: S
authors.lastname: Gaggar
authors.forename: John
authors.initials: J
authors.lastname: Scott
authors.forename: Nicholas
authors.initials: N
authors.lastname: Thompson
keywords: Adalimumab; Anti-tumor necrosis factor therapy; Crohn’s disease; Pyloric stenosis